风暴后的平静:COVID-19疫情后安全重启辅助生殖治疗
本文由ESHRE发布,旨在指导辅助生殖服务在COVID-19疫情后安全重启治疗,并应对未来可能的疫情波。指南涵盖患者选择与知情同意、员工与患者分诊和检测、ART服务调整、治疗规划及行为准则。所述行动方案也可应用于其他医学领域的类似紧急情况。
要点
- 指南强调患者选择与知情同意、分诊和检测。
- 需调整ART服务并制定治疗规划与行为准则。
- 行动方案可推广至其他医学领域应急管理。
核心结论
- ESHRE发布的指导有助于辅助生殖服务在COVID-19疫情后安全重启治疗,并应对未来疫情波。
研究设计与样本
- ESHRE动员资源收集、分析、监测、准备和传播与ART及早期妊娠相关的SARS-CoV-2知识,并据此制定指导。
主要发现
- 指南包括患者选择与知情同意、员工与患者分诊和检测、ART服务调整、治疗规划及行为准则等信息。
- 所述举措并非COVID特异性,类似行动计划可有效应用于未来其他医学领域的紧急情况。
关键数值与推荐
- 推荐涉及患者选择与知情同意、员工与患者分诊和检测、ART服务调整、治疗规划及行为准则。
临床怎么用
- 辅助生殖服务可依据该指南组织和管理治疗重启,并应对未来COVID-19疫情波。
- 其他医学领域可借鉴该行动方案管理类似紧急情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future.
引用
- Gianaroli L, Ata B, Lundin K, et al. The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic. Hum Reprod. 2021. PMID: 33017461. doi:10.1093/humrep/deaa285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。